Bacteroides fragilis BF839

N/A

Report date: 2024/01/10 17:54:29

Base Information

Drug NameBacteroides fragilis BF839
Drug Alias Name脆弱拟杆菌BF839Bacteroides fragilis BF-839脆弱拟杆菌BF-839
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsChemotherapy-induced myelosuppressionAutism Spectrum DisorderAutoimmune Diseases +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesSecond Affiliated Hospital Of Guangzhou Medical UniversityWest China Hospital Of Sichuan UniversityShenzhen Children'S Hospital
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced myelosuppressionAutism Spectrum DisorderAutoimmune Diseases +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A